Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Research

Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production

Authors: Qing-Meng Zhang, Wu-Qi Song, Yu-Jun Li, Jun Qian, Ai-Xia Zhai, Jing Wu, Ai-Mei Li, Jun-Ming He, Jin-Yun Zhao, Xin Yu, Lan-Lan Wei, Feng-Min Zhang

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Background

Recent studies have revealed that Mitochondrial Antiviral Signaling (MAVS) protein plays an essential role in the inhibition of viral infection through type I interferon (IFN) pathway. It has been shown that 3C (pro) cysteine protease of coxsackievirus B3 (CVB3) cleaves MAVS to inhibit type I IFNs induction. Other workers also found that MAVS knock-out mice suffered CVB3 susceptibility and severe histopathological change. Accordingly,our experiments were designed to explore the protection of over-expressing MAVS against CVB3 infection and the possible mechanism.

Results

In this study, HeLa cells (transfected with MAVS constructs pre- or post- exposure to CVB3) were used to analyze the function of exogenous MAVS on CVB3 infection. The results revealed that though CVB3 infection induced production of type I IFNs, viral replication and cell death were not effectively inhibited. Similarly, exogenous MAVS increased type I IFNs moderately. Morever, we observed robust production of type I IFNs in CVB3 post-infected HeLa cells thereby successfully inhibiting CVB3 infection, as well formation of cytopathic effect (CPE) and cell death. Finally, introduction of exogenous MAVS into CVB3 pre-infected cells also restricted viral infection efficiently by greatly up-regulating IFNs.

Conclusions

In summary, exogenous MAVS effectively prevents and controls CVB3 infection by modulating and promoting the production of type I IFNs. The IFNs level in MAVS over-expressing cells is still tightly regulated by CVB3 infection. Thus, the factors that up-regulate MAVS might be an alternative prescription in CVB3-related syndromes by enhancing IFNs production.
Appendix
Available only for authorised users
Literature
1.
go back to reference Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122: 669-682. 10.1016/j.cell.2005.08.012PubMedCrossRef Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122: 669-682. 10.1016/j.cell.2005.08.012PubMedCrossRef
2.
go back to reference Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB: VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19: 727-740. 10.1016/j.molcel.2005.08.014PubMedCrossRef Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB: VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19: 727-740. 10.1016/j.molcel.2005.08.014PubMedCrossRef
3.
go back to reference Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6: 981-988. 10.1038/ni1243PubMedCrossRef Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6: 981-988. 10.1038/ni1243PubMedCrossRef
4.
go back to reference Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437: 1167-1172. 10.1038/nature04193PubMedCrossRef Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437: 1167-1172. 10.1038/nature04193PubMedCrossRef
5.
go back to reference Honda K, Takaoka A, Taniguchi T: Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25: 349-360. 10.1016/j.immuni.2006.08.009PubMedCrossRef Honda K, Takaoka A, Taniguchi T: Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25: 349-360. 10.1016/j.immuni.2006.08.009PubMedCrossRef
6.
go back to reference Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T: Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315: 1274-1278. 10.1126/science.1136567PubMedCrossRef Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T: Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315: 1274-1278. 10.1126/science.1136567PubMedCrossRef
7.
go back to reference Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR: Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007, 6: 975-990. 10.1038/nrd2422PubMedCrossRef Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR: Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007, 6: 975-990. 10.1038/nrd2422PubMedCrossRef
8.
go back to reference Broquet AH, Hirata Y, McAllister CS, Kagnoff MF: RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J Immunol 2011, 186: 1618-1626. 10.4049/jimmunol.1002862PubMedCrossRef Broquet AH, Hirata Y, McAllister CS, Kagnoff MF: RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J Immunol 2011, 186: 1618-1626. 10.4049/jimmunol.1002862PubMedCrossRef
9.
go back to reference Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M: Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006, 103: 8459-8464. 10.1073/pnas.0603082103PubMedPubMedCentralCrossRef Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M: Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006, 103: 8459-8464. 10.1073/pnas.0603082103PubMedPubMedCentralCrossRef
10.
go back to reference Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S: Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006, 203: 1795-1803. 10.1084/jem.20060792PubMedPubMedCentralCrossRef Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S: Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006, 203: 1795-1803. 10.1084/jem.20060792PubMedPubMedCentralCrossRef
11.
go back to reference Ikegame S, Takeda M, Ohno S, Nakatsu Y, Nakanishi Y, Yanagi Y: Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84: 372-379. 10.1128/JVI.01690-09PubMedPubMedCentralCrossRef Ikegame S, Takeda M, Ohno S, Nakatsu Y, Nakanishi Y, Yanagi Y: Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84: 372-379. 10.1128/JVI.01690-09PubMedPubMedCentralCrossRef
12.
go back to reference Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441: 101-105. 10.1038/nature04734PubMedCrossRef Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441: 101-105. 10.1038/nature04734PubMedCrossRef
13.
go back to reference Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P: Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 2000, 81: 2755-2762.PubMedCrossRef Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P: Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 2000, 81: 2755-2762.PubMedCrossRef
14.
go back to reference Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ: The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006, 24: 633-642. 10.1016/j.immuni.2006.04.004PubMedCrossRef Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ: The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006, 24: 633-642. 10.1016/j.immuni.2006.04.004PubMedCrossRef
15.
go back to reference Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82: 335-345. 10.1128/JVI.01080-07PubMedPubMedCentralCrossRef Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82: 335-345. 10.1128/JVI.01080-07PubMedPubMedCentralCrossRef
16.
go back to reference Biacchesi S, LeBerre M, Lamoureux A, Louise Y, Lauret E, Boudinot P, Bremont M: Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses. J Virol 2009, 83: 7815-7827. 10.1128/JVI.00404-09PubMedPubMedCentralCrossRef Biacchesi S, LeBerre M, Lamoureux A, Louise Y, Lauret E, Boudinot P, Bremont M: Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses. J Virol 2009, 83: 7815-7827. 10.1128/JVI.00404-09PubMedPubMedCentralCrossRef
17.
go back to reference Kim KS, Hufnagel G, Chapman NM, Tracy S: The group B coxsackieviruses and myocarditis. Rev Med Virol 2001, 11: 355-368. 10.1002/rmv.326PubMedCrossRef Kim KS, Hufnagel G, Chapman NM, Tracy S: The group B coxsackieviruses and myocarditis. Rev Med Virol 2001, 11: 355-368. 10.1002/rmv.326PubMedCrossRef
18.
go back to reference Drescher KM, Tracy SM: The CVB and etiology of type 1 diabetes. Curr Top Microbiol Immunol 2008, 323: 259-274. 10.1007/978-3-540-75546-3_12PubMed Drescher KM, Tracy SM: The CVB and etiology of type 1 diabetes. Curr Top Microbiol Immunol 2008, 323: 259-274. 10.1007/978-3-540-75546-3_12PubMed
19.
go back to reference Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL: Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003, 163: 1379-1393. 10.1016/S0002-9440(10)63496-7PubMedPubMedCentralCrossRef Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL: Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003, 163: 1379-1393. 10.1016/S0002-9440(10)63496-7PubMedPubMedCentralCrossRef
20.
go back to reference Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW: MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol 2010, 84: 254-260. 10.1128/JVI.00631-09PubMedPubMedCentralCrossRef Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW: MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol 2010, 84: 254-260. 10.1128/JVI.00631-09PubMedPubMedCentralCrossRef
21.
go back to reference Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB: The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011, 7: e1001311. 10.1371/journal.ppat.1001311PubMedPubMedCentralCrossRef Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB: The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011, 7: e1001311. 10.1371/journal.ppat.1001311PubMedPubMedCentralCrossRef
22.
go back to reference Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL: Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002, 76: 4430-4440. 10.1128/JVI.76.9.4430-4440.2002PubMedPubMedCentralCrossRef Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL: Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002, 76: 4430-4440. 10.1128/JVI.76.9.4430-4440.2002PubMedPubMedCentralCrossRef
24.
go back to reference Meylan E, Tschopp J: Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 2006, 22: 561-569. 10.1016/j.molcel.2006.05.012PubMedCrossRef Meylan E, Tschopp J: Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 2006, 22: 561-569. 10.1016/j.molcel.2006.05.012PubMedCrossRef
25.
go back to reference Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ: MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146: 448-461. 10.1016/j.cell.2011.06.041PubMedPubMedCentralCrossRef Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ: MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146: 448-461. 10.1016/j.cell.2011.06.041PubMedPubMedCentralCrossRef
26.
go back to reference Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G, Ehrhardt C, Wolff T: Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 2005, 102: 13640-13645. 10.1073/pnas.0502883102PubMedPubMedCentralCrossRef Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G, Ehrhardt C, Wolff T: Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 2005, 102: 13640-13645. 10.1073/pnas.0502883102PubMedPubMedCentralCrossRef
27.
go back to reference Li XD, Sun L, Seth RB, Pineda G, Chen ZJ: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102: 17717-17722. 10.1073/pnas.0508531102PubMedPubMedCentralCrossRef Li XD, Sun L, Seth RB, Pineda G, Chen ZJ: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102: 17717-17722. 10.1073/pnas.0508531102PubMedPubMedCentralCrossRef
28.
go back to reference Kochs G, Garcia-Sastre A, Martinez-Sobrido L: Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007, 81: 7011-7021. 10.1128/JVI.02581-06PubMedPubMedCentralCrossRef Kochs G, Garcia-Sastre A, Martinez-Sobrido L: Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007, 81: 7011-7021. 10.1128/JVI.02581-06PubMedPubMedCentralCrossRef
29.
go back to reference Brunetti L, DeSantis ER: Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm 2008, 65: 132-137. 10.2146/ajhp060586PubMedCrossRef Brunetti L, DeSantis ER: Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm 2008, 65: 132-137. 10.2146/ajhp060586PubMedCrossRef
30.
go back to reference Heim A, Weiss S: Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity. Med Microbiol Immunol 2004, 193: 149-154. 10.1007/s00430-003-0200-3PubMedCrossRef Heim A, Weiss S: Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity. Med Microbiol Immunol 2004, 193: 149-154. 10.1007/s00430-003-0200-3PubMedCrossRef
31.
go back to reference Nicodemus CF, Berek JS: TLR3 agonists as immunotherapeutic agents. Immunotherapy 2010, 2: 137-140. 10.2217/imt.10.8PubMedCrossRef Nicodemus CF, Berek JS: TLR3 agonists as immunotherapeutic agents. Immunotherapy 2010, 2: 137-140. 10.2217/imt.10.8PubMedCrossRef
32.
go back to reference Norris D, Loh PC: Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator. Proc Soc Exp Biol Med 1973, 142: 133-136.PubMedCrossRef Norris D, Loh PC: Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator. Proc Soc Exp Biol Med 1973, 142: 133-136.PubMedCrossRef
33.
go back to reference Padalko E, Nuyens D, De Palma A, Verbeken E, Aerts JL, De Clercq E, Carmeliet P, Neyts J: The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother 2004, 48: 267-274. 10.1128/AAC.48.1.267-274.2004PubMedPubMedCentralCrossRef Padalko E, Nuyens D, De Palma A, Verbeken E, Aerts JL, De Clercq E, Carmeliet P, Neyts J: The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother 2004, 48: 267-274. 10.1128/AAC.48.1.267-274.2004PubMedPubMedCentralCrossRef
34.
go back to reference Schulte BM, Kramer M, Ansems M, Lanke KH, van Doremalen N, Piganelli JD, Bottino R, Trucco M, Galama JM, Adema GJ, van Kuppeveld FJ: Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes 2010, 59: 1182-1191. 10.2337/db09-1071PubMedPubMedCentralCrossRef Schulte BM, Kramer M, Ansems M, Lanke KH, van Doremalen N, Piganelli JD, Bottino R, Trucco M, Galama JM, Adema GJ, van Kuppeveld FJ: Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes 2010, 59: 1182-1191. 10.2337/db09-1071PubMedPubMedCentralCrossRef
35.
go back to reference Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL: Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 2001, 75: 2377-2387. 10.1128/JVI.75.5.2377-2387.2001PubMedPubMedCentralCrossRef Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL: Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 2001, 75: 2377-2387. 10.1128/JVI.75.5.2377-2387.2001PubMedPubMedCentralCrossRef
36.
go back to reference Huber SA, Job LP, Woodruff JF: Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am J Pathol 1980, 98: 681-694.PubMedPubMedCentral Huber SA, Job LP, Woodruff JF: Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am J Pathol 1980, 98: 681-694.PubMedPubMedCentral
37.
go back to reference Johnsen IB, Nguyen TT, Bergstroem B, Fitzgerald KA, Anthonsen MW: The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J Biol Chem 2009, 284: 19122-19131. 10.1074/jbc.M808233200PubMedPubMedCentralCrossRef Johnsen IB, Nguyen TT, Bergstroem B, Fitzgerald KA, Anthonsen MW: The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J Biol Chem 2009, 284: 19122-19131. 10.1074/jbc.M808233200PubMedPubMedCentralCrossRef
38.
go back to reference Qian J, Zhai A, Kao W, Li Y, Song W, Fu Y, Chen X, Zhang Q, Wu J, Li H, et al.: Modulation of miR-122 on persistently borna disease virus infected human oligodendroglial cells. Antiviral Res 2010, 87: 249-256. 10.1016/j.antiviral.2010.05.011PubMedCrossRef Qian J, Zhai A, Kao W, Li Y, Song W, Fu Y, Chen X, Zhang Q, Wu J, Li H, et al.: Modulation of miR-122 on persistently borna disease virus infected human oligodendroglial cells. Antiviral Res 2010, 87: 249-256. 10.1016/j.antiviral.2010.05.011PubMedCrossRef
39.
go back to reference Hayashi F, Means TK, Luster AD: Toll-like receptors stimulate human neutrophil function. Blood 2003, 102: 2660-2669. 10.1182/blood-2003-04-1078PubMedCrossRef Hayashi F, Means TK, Luster AD: Toll-like receptors stimulate human neutrophil function. Blood 2003, 102: 2660-2669. 10.1182/blood-2003-04-1078PubMedCrossRef
40.
go back to reference Fukuda Y, Berry TL, Nelson M, Hunter CL, Fukuhara K, Imai H, Ito S, Granholm-Bentley AC, Kaplan AP, Mutoh T: Stimulated neuronal expression of brain-derived neurotrophic factor by neurotropin. Mol Cell Neurosci 2010, 45: 226-233. 10.1016/j.mcn.2010.06.013PubMedCrossRef Fukuda Y, Berry TL, Nelson M, Hunter CL, Fukuhara K, Imai H, Ito S, Granholm-Bentley AC, Kaplan AP, Mutoh T: Stimulated neuronal expression of brain-derived neurotrophic factor by neurotropin. Mol Cell Neurosci 2010, 45: 226-233. 10.1016/j.mcn.2010.06.013PubMedCrossRef
Metadata
Title
Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production
Authors
Qing-Meng Zhang
Wu-Qi Song
Yu-Jun Li
Jun Qian
Ai-Xia Zhai
Jing Wu
Ai-Mei Li
Jun-Ming He
Jin-Yun Zhao
Xin Yu
Lan-Lan Wei
Feng-Min Zhang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-312

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.